Multiple courses of stereotactic re-irradiation in recurrent oligodendroglioma: a case report.

Authors

Shannon Fogh, Department of Radiation Oncology, University of California San FranciscoFollow
Charles Glass, Department of Radiation Oncology, Thomas Jefferson UniversityFollow
David W Andrews, Department of Neurosurgery, Thomas Jefferson UniversityFollow
Maria Werner-Wasik, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

5-14-2011

Comments

This article has been peer reviewed and is published in the Journal of Medical Case Reports 2011, 5:183. The published version is available at DOI: 10.1186/1752-1947-5-183. ©BioMed Central Ltd.

Abstract

INTRODUCTION: High grade gliomas are an insidious disease associated with an extremely poor prognosis. The role of re-irradiation for recurrent gliomas is unclear but several retrospective studies have indicated mild toxicity and modest outcomes with this regimen. With subsequent progression, it is unclear what options remain and more radiotherapy is rarely offered for fear of surpassing normal central nervous system tissue tolerance and causing significant side effects without significant benefit.

CASE PRESENTATION: In this report, we describe a 37-year-old Caucasian male initially diagnosed with a grade IV oligodendroglioma, who received multiple courses of re-irradiation and experienced a survival of 10 years with minimal cognitive or neurologic deficits.

CONCLUSION: Significant toxicity with multiple courses of radiation does not always occur. Re-irradiation should be considered in a salvage setting.

Recommended Citation

Fogh, Shannon; Glass, Charles; Andrews, David W; and Werner-Wasik, Maria, "Multiple courses of stereotactic re-irradiation in recurrent oligodendroglioma: a case report." (2011). Department of Radiation Oncology Faculty Papers. Paper 22.
https://jdc.jefferson.edu/radoncfp/22

PubMed ID

21569607